Ixazomib Impurity 56 CAS CATO-C4X-126756

Purity >95%In StockPharmacopoeial Impurity Standards
CAS No.CATO-C4X-126756
Molecular FormulaC15H28BNO2
Molecular WeightN/A
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Ixazomib Impurity 56 CAS CATO-C4X-126756 chemical structure

Description

CATO manufactures Ixazomib Impurity 56 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

As a process- or degradation-related impurity, Ixazomib Impurity 56 (CAS CATO-C4X-126756, C15H28BNO2HCl) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.

Owing to an amide group, a carboxylic acid group, a hydroxyl group, an ether linkage, chlorine substitution, Ixazomib Impurity 56 is typically white to off-white crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 301.66 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

Physical & Chemical Properties

Molecular FormulaC15H28BNO2 HCl
Molecular Weight301.66 g/mol
Purity>95%
StorageStore at 2-8°C, protect from light
Solubility (reference)Soluble in chloroform, dichloromethane, ethyl acetate, DMSO
StabilityLight-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions
Degree of Unsaturation (DBE)1.5
Halogen ContentCl-containing
Nitrogen Atoms1

Related Ixazomib Standards

Recommended Standards

Why CATO?